Sirion Biotech
Type:
Adeno Viral Vector
shRNA
Gene Knockdown Cells
Description: SIRION Biotech was founded in 2006 in Munich and maintains offices in Tokyo and New Hampshire. It stands for sophisticated cell modeling and viral vector platforms. These enable much improved target identification and compound screening in the drug, the food & cosmetic industries. Its technology has over the years been validated in more than 250 commercial projects with more than 70 academic and industrial organizations worldwide. As a result, primary cell immortalizations are being technically advanced, so are the recombinant construction of adenovirus serotype vectors serving for gene therapy applications and novel vaccine
City: Durham
State: North Carolina
Contact Person: Kathrin Schmitt
Contact email: infoUSA@sirion-biotech.com
